Systematic Analysis of Mobile Genetic Elements Mediating β-Lactamase Gene Amplification in Noncarbapenemase-Producing Carbapenem-Resistant


Journal

mSystems
ISSN: 2379-5077
Titre abrégé: mSystems
Pays: United States
ID NLM: 101680636

Informations de publication

Date de publication:
26 10 2022
Historique:
pubmed: 30 8 2022
medline: 30 8 2022
entrez: 29 8 2022
Statut: ppublish

Résumé

Noncarbapenemase-producing carbapenem-resistant

Identifiants

pubmed: 36036505
doi: 10.1128/msystems.00476-22
pmc: PMC9601100
doi:

Substances chimiques

Carbapenems 0
Anti-Bacterial Agents 0
beta-Lactamases EC 3.5.2.6
Porins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Pagination

e0047622

Subventions

Organisme : NIAID NIH HHS
ID : T32 AI141349
Pays : United States
Organisme : NIH HHS
ID : S10 OD024977
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI134637
Pays : United States
Organisme : NIAID NIH HHS
ID : K24 AI121296
Pays : United States
Organisme : NIAID NIH HHS
ID : K01 AI148593
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM133904
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI148342
Pays : United States

Références

Genome Med. 2020 Jan 20;12(1):10
pubmed: 31955713
Antimicrob Agents Chemother. 2018 Apr 26;62(5):
pubmed: 29439976
Plasmid. 2020 Sep;111:102530
pubmed: 32871211
Antimicrob Agents Chemother. 2011 Nov;55(11):5370-3
pubmed: 21844325
J Antimicrob Chemother. 2019 Nov 1;74(11):3179-3183
pubmed: 31411684
Genome Biol. 2020 Jul 22;21(1):180
pubmed: 32698896
Antimicrob Agents Chemother. 2020 Jan 27;64(2):
pubmed: 31658962
Antimicrob Agents Chemother. 2018 Dec 21;63(1):
pubmed: 30373801
PLoS One. 2018 Sep 6;13(9):e0203323
pubmed: 30188911
Microb Drug Resist. 2022 Apr;28(4):389-397
pubmed: 35172110
Microb Genom. 2017 Jun 9;3(8):e000118
pubmed: 29026658
Antimicrob Agents Chemother. 2013 Aug;57(8):3941-9
pubmed: 23733461
Microbiol Spectr. 2016 Jun;4(3):
pubmed: 27337454
Clin Infect Dis. 2022 Feb 11;74(3):395-406
pubmed: 33970222
Nat Commun. 2020 Oct 1;11(1):4915
pubmed: 33004811
Nat Commun. 2021 Jul 7;12(1):4188
pubmed: 34234121
Clin Infect Dis. 2019 Nov 13;69(Suppl 7):S521-S528
pubmed: 31724045
Nat Commun. 2018 Nov 30;9(1):5114
pubmed: 30504855
Environ Microbiol Rep. 2013 Feb;5(1):58-65
pubmed: 23757131
J Antimicrob Chemother. 2013 Jan;68(1):51-9
pubmed: 22977158
J Antimicrob Chemother. 2020 Jan 1;75(1):77-85
pubmed: 31613964
Front Microbiol. 2021 Feb 10;11:623574
pubmed: 33643226
Expert Rev Anti Infect Ther. 2016;14(1):95-108
pubmed: 26535959
Antimicrob Agents Chemother. 2019 Sep 23;63(10):
pubmed: 31383670
FEMS Microbiol Lett. 2013 Apr;341(1):27-36
pubmed: 23330672
Clin Infect Dis. 2014 May;58(9):1274-83
pubmed: 24463280
Bioinformatics. 2019 Feb 1;35(3):526-528
pubmed: 30016406
Clin Microbiol Rev. 2015 Jul;28(3):565-91
pubmed: 25926236
Bioinformatics. 2010 Sep 15;26(18):2334-5
pubmed: 20624783
Mol Biol Evol. 1997 Jul;14(7):685-95
pubmed: 9254330
Lancet Infect Dis. 2020 Jun;20(6):731-741
pubmed: 32151332
Comput Struct Biotechnol J. 2021 Mar 29;19:1896-1906
pubmed: 33897984
JAMA. 2015 Oct 13;314(14):1479-87
pubmed: 26436831
mSystems. 2021 Oct 26;6(5):e0019421
pubmed: 34519526
Antimicrob Agents Chemother. 2009 Feb;53(2):832-4
pubmed: 19029330
Microb Genom. 2018 Jul;4(7):
pubmed: 29916797
Bioinformatics. 2018 Mar 1;34(5):867-868
pubmed: 29096012
Nat Microbiol. 2019 Mar;4(3):504-514
pubmed: 30742072
J Antimicrob Chemother. 2021 Jan 19;76(2):385-395
pubmed: 33164081
Clin Infect Dis. 2020 Aug 14;71(4):960-967
pubmed: 31751470
J Clin Microbiol. 2015 Aug;53(8):2410-26
pubmed: 25972421
Infect Genet Evol. 2012 Jul;12(5):883-93
pubmed: 22414916
J Antimicrob Chemother. 2019 Feb 1;74(2):326-333
pubmed: 30388219
Clin Microbiol Rev. 2018 Aug 1;31(4):
pubmed: 30068738
Open Forum Infect Dis. 2020 Jul 17;7(8):ofaa299
pubmed: 32855986
Antimicrob Agents Chemother. 2015 Dec;59(12):7753-61
pubmed: 26438498
Mol Biol Evol. 2015 Dec;32(12):3252-63
pubmed: 26358402
mBio. 2014 Oct 07;5(5):e01801-14
pubmed: 25293759
Mol Biol Evol. 2020 May 1;37(5):1530-1534
pubmed: 32011700
J Antimicrob Chemother. 2016 Sep;71(9):2484-8
pubmed: 27365186
Clin Infect Dis. 2022 Aug 24;75(1):47-54
pubmed: 34618008
mBio. 2018 Apr 24;9(2):
pubmed: 29691340
Mol Biol Evol. 2018 Feb 1;35(2):518-522
pubmed: 29077904
Microb Genom. 2018 Aug;4(8):
pubmed: 30052170
Genome Res. 2015 Jul;25(7):1043-55
pubmed: 25977477
mBio. 2022 Apr 26;13(2):e0049722
pubmed: 35357213
J Antimicrob Chemother. 2013 Jun;68(6):1319-26
pubmed: 23478794
mSphere. 2016 Apr 06;1(2):
pubmed: 27303727
Mol Biol Evol. 2014 Jun;31(6):1526-35
pubmed: 24659815
Wellcome Open Res. 2018 Jul 30;3:93
pubmed: 30345380
Nat Rev Microbiol. 2020 Jun;18(6):344-359
pubmed: 32055025
Nat Methods. 2017 Jun;14(6):587-589
pubmed: 28481363
BMC Bioinformatics. 2018 Aug 29;19(1):307
pubmed: 30157759
mBio. 2018 Apr 24;9(2):
pubmed: 29691332
Genome Biol. 2016 Jun 20;17(1):132
pubmed: 27323842
J Mol Biol. 1981 Feb 15;146(1):23-43
pubmed: 7021856
Elife. 2021 Apr 19;10:
pubmed: 33871353
Clin Infect Dis. 2021 Dec 6;73(11):e3842-e3850
pubmed: 33106863
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D32-6
pubmed: 16381877
J Clin Microbiol. 2012 Apr;50(4):1355-61
pubmed: 22238442
Nat Microbiol. 2019 Nov;4(11):1919-1929
pubmed: 31358985
Antimicrob Agents Chemother. 2016 Dec 27;61(1):
pubmed: 27799202

Auteurs

W C Shropshire (WC)

Department of Infectious Diseases and Infection Control, The University of Texas MD Anderson Cancer Centergrid.240145.6, Houston, Texas, USA.

A Konovalova (A)

Department of Microbiology and Molecular Genetics, McGovern Medical School, The University of Texas Health Science Center at Houstongrid.267308.8, Houston, Texas, USA.

P McDaneld (P)

Division of Pharmacy, The University of Texas MD Anderson Cancer Centergrid.240145.6, Houston, Texas, USA.

M Gohel (M)

Department of Infectious Diseases and Infection Control, The University of Texas MD Anderson Cancer Centergrid.240145.6, Houston, Texas, USA.

B Strope (B)

Department of Infectious Diseases and Infection Control, The University of Texas MD Anderson Cancer Centergrid.240145.6, Houston, Texas, USA.

P Sahasrabhojane (P)

Department of Infectious Diseases and Infection Control, The University of Texas MD Anderson Cancer Centergrid.240145.6, Houston, Texas, USA.

C N Tran (CN)

Department of Infectious Diseases and Infection Control, The University of Texas MD Anderson Cancer Centergrid.240145.6, Houston, Texas, USA.

D Greenberg (D)

Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas, USA.
Department of Microbiology, UT Southwestern Medical Center, Dallas, Texas, USA.

J Kim (J)

Department of Bioinformatics, UT Southwestern Medical Center, Dallas, Texas, USA.

X Zhan (X)

Department of Bioinformatics, UT Southwestern Medical Center, Dallas, Texas, USA.

S Aitken (S)

Division of Pharmacy, Michigan Medicine at University of Michigan, Ann Arbor, Michigan, USA.

M Bhatti (M)

Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Centergrid.240145.6, Houston, Texas, USA.

T C Savidge (TC)

Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas, USA.
Department of Pathology, Texas Children's Hospital, Houston, Texas, USA.

T J Treangen (TJ)

Department of Computer Science, Rice University, Houston, Texas, USA.

B M Hanson (BM)

Center for Infectious Diseases, School of Public Health, University of Texas Health Science Center, Houston, Texas, USA.

C A Arias (CA)

Department of Medicine, Houston Methodist Hospital, Houston, Texas, USA.

S A Shelburne (SA)

Department of Infectious Diseases and Infection Control, The University of Texas MD Anderson Cancer Centergrid.240145.6, Houston, Texas, USA.
Department of Genomic Medicine, The University of Texas MD Anderson Cancer Centergrid.240145.6, Houston, Texas, USA.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH